Aaron shares his passion for advancing cell therapy to eliminate the need for insulin in diabetes treatment, aiming for long-term solutions beyond current artificial pancreas technology. The focus is on preventing and potentially curing type 1 diabetes, aligning with the organization's core mission of seeking cures.
